CompletedNCT06477575
Effectiveness of Technology-based Interventions for the Improvement of Cognitive Processes in ADHD.
It focuses on ADHD and currently lists study information in Spain.
ADHDDeviceFrom 6 Years to 17 Years
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
- Listed locations
- Badajoz, SpainSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
Study information
Study start dateStarted: March 1, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- University of Extremadura
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE, OTHER
- Study phase
- Not clearly listed
- Locations
- Spain
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT06477575
- Official title
- Effectiveness of Technology-based Interventions for the Improvement of Cognitive Processes in Children and Adolescents With ADHD.
Recruitment & locations
CompletedBadajoz
Questions about this study
Who is behind this study?
The study sponsor is University of Extremadura, a university.
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT00700427
A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study is completed. It focuses on ADHD and currently lists study information in Austria, Belgium, Finland, France, Germany, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
CompletedEUCTR 2007-002111-82
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS® methylphenidate (54 and 72 mg/day) i...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
CompletedEUCTR 2009-018161-12
A Phase 3, Double-blind, Placebo-controlled, Multicentre, Randomised withdrawal, Long-term Maintenance of Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children and Adol...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.